FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4287149233> ?p ?o ?g. }

• W4287149233 endingPage "3022" @default.
• W4287149233 startingPage "3022" @default.
• W4287149233 abstract "Background: Pancreatic beta cells regulate bioenergetics efficiency and secret insulin in response to glucose and nutrient availability. The mechanistic Target of Rapamycin (mTOR) network orchestrates pancreatic progenitor cell growth and metabolism by nucleating two complexes, mTORC1 and mTORC2. Objective: To determine the impact of mTORC1/mTORC2 inhibition on amino acid metabolism in mouse pancreatic beta cells (Beta-TC-6 cells, ATCC-CRL-11506) using high-resolution metabolomics (HRM) and live-mitochondrial functions. Methods: Pancreatic beta TC-6 cells were incubated for 24 h with either: RapaLink-1 (RL); Torin-2 (T); rapamycin (R); metformin (M); a combination of RapaLink-1 and metformin (RLM); Torin-2 and metformin (TM); compared to the control. We applied high-resolution mass spectrometry (HRMS) LC-MS/MS untargeted metabolomics to compare the twenty natural amino acid profiles to the control. In addition, we quantified the bioenergetics dynamics and cellular metabolism by live-cell imaging and the MitoStress Test XF24 (Agilent, Seahorse). The real-time, live-cell approach simultaneously measures the oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) to determine cellular respiration and metabolism. Statistical significance was assessed using ANOVA on Ranks and post-hoc Welch t-Tests. Results: RapaLink-1, Torin-2, and rapamycin decreased L-aspartate levels compared to the control (p = 0.006). Metformin alone did not affect L-aspartate levels. However, L-asparagine levels decreased with all treatment groups compared to the control (p = 0.03). On the contrary, L-glutamate and glycine levels were reduced only by mTORC1/mTORC2 inhibitors RapaLink-1 and Torin-2, but not by rapamycin or metformin. The metabolic activity network model predicted that L-aspartate and AMP interact within the same activity network. Live-cell bioenergetics revealed that ATP production was significantly reduced in RapaLink-1 (122.23 ± 33.19), Torin-2 (72.37 ± 17.33) treated cells, compared to rapamycin (250.45 ± 9.41) and the vehicle control (274.23 ± 38.17), p < 0.01. However, non-mitochondrial oxygen consumption was not statistically different between RapaLink-1 (67.17 ± 3.52), Torin-2 (55.93 ± 8.76), or rapamycin (80.01 ± 4.36, p = 0.006). Conclusions: Dual mTORC1/mTORC2 inhibition by RapaLink-1 and Torin-2 differentially altered the amino acid profile and decreased mitochondrial respiration compared to rapamycin treatment which only blocks the FRB domain on mTOR. Third-generation mTOR inhibitors may alter the mitochondrial dynamics and reveal a bioenergetics profile that could be targeted to reduce mitochondrial stress." @default.
• W4287149233 created "2022-07-25" @default.
• W4287149233 creator A5008360619 @default.
• W4287149233 creator A5019623840 @default.
• W4287149233 creator A5077165139 @default.
• W4287149233 date "2022-07-22" @default.
• W4287149233 modified "2023-09-26" @default.
• W4287149233 title "mTORC1 and mTORC2 Complexes Regulate the Untargeted Metabolomics and Amino Acid Metabolites Profile through Mitochondrial Bioenergetic Functions in Pancreatic Beta Cells" @default.
• W4287149233 cites W1968092563 @default.
• W4287149233 cites W1976643149 @default.
• W4287149233 cites W2003819643 @default.
• W4287149233 cites W2006315039 @default.
• W4287149233 cites W2025944550 @default.
• W4287149233 cites W2027021033 @default.
• W4287149233 cites W2032462280 @default.
• W4287149233 cites W2074876140 @default.
• W4287149233 cites W2079172266 @default.
• W4287149233 cites W2080046774 @default.
• W4287149233 cites W2083941523 @default.
• W4287149233 cites W2087144289 @default.
• W4287149233 cites W2114648573 @default.
• W4287149233 cites W2123795089 @default.
• W4287149233 cites W2131878480 @default.
• W4287149233 cites W2138457132 @default.
• W4287149233 cites W2155109292 @default.
• W4287149233 cites W2164316746 @default.
• W4287149233 cites W2168590651 @default.
• W4287149233 cites W2293646973 @default.
• W4287149233 cites W2324021033 @default.
• W4287149233 cites W2529255474 @default.
• W4287149233 cites W2548530122 @default.
• W4287149233 cites W2593816418 @default.
• W4287149233 cites W2597290376 @default.
• W4287149233 cites W2602697787 @default.
• W4287149233 cites W2605743056 @default.
• W4287149233 cites W2608815200 @default.
• W4287149233 cites W2750516258 @default.
• W4287149233 cites W2754928426 @default.
• W4287149233 cites W2765242536 @default.
• W4287149233 cites W2790809691 @default.
• W4287149233 cites W2794334542 @default.
• W4287149233 cites W2888345444 @default.
• W4287149233 cites W2896869836 @default.
• W4287149233 cites W2913763562 @default.
• W4287149233 cites W2914253295 @default.
• W4287149233 cites W2943931937 @default.
• W4287149233 cites W2952521211 @default.
• W4287149233 cites W2999461658 @default.
• W4287149233 cites W3000563588 @default.
• W4287149233 cites W3013877673 @default.
• W4287149233 cites W3199970584 @default.
• W4287149233 cites W3209660599 @default.
• W4287149233 doi "https://doi.org/10.3390/nu14153022" @default.
• W4287149233 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35893876" @default.
• W4287149233 hasPublicationYear "2022" @default.
• W4287149233 type Work @default.
• W4287149233 citedByCount "1" @default.
• W4287149233 countsByYear W42871492332023 @default.
• W4287149233 crossrefType "journal-article" @default.
• W4287149233 hasAuthorship W4287149233A5008360619 @default.
• W4287149233 hasAuthorship W4287149233A5019623840 @default.
• W4287149233 hasAuthorship W4287149233A5077165139 @default.
• W4287149233 hasBestOaLocation W42871492331 @default.
• W4287149233 hasConcept C100206155 @default.
• W4287149233 hasConcept C107846503 @default.
• W4287149233 hasConcept C134018914 @default.
• W4287149233 hasConcept C135870905 @default.
• W4287149233 hasConcept C21565614 @default.
• W4287149233 hasConcept C2779306644 @default.
• W4287149233 hasConcept C2780323712 @default.
• W4287149233 hasConcept C28859421 @default.
• W4287149233 hasConcept C55493867 @default.
• W4287149233 hasConcept C60644358 @default.
• W4287149233 hasConcept C62231903 @default.
• W4287149233 hasConcept C62478195 @default.
• W4287149233 hasConcept C86554907 @default.
• W4287149233 hasConcept C86803240 @default.
• W4287149233 hasConcept C95444343 @default.
• W4287149233 hasConcept C98490376 @default.
• W4287149233 hasConceptScore W4287149233C100206155 @default.
• W4287149233 hasConceptScore W4287149233C107846503 @default.
• W4287149233 hasConceptScore W4287149233C134018914 @default.
• W4287149233 hasConceptScore W4287149233C135870905 @default.
• W4287149233 hasConceptScore W4287149233C21565614 @default.
• W4287149233 hasConceptScore W4287149233C2779306644 @default.
• W4287149233 hasConceptScore W4287149233C2780323712 @default.
• W4287149233 hasConceptScore W4287149233C28859421 @default.
• W4287149233 hasConceptScore W4287149233C55493867 @default.
• W4287149233 hasConceptScore W4287149233C60644358 @default.
• W4287149233 hasConceptScore W4287149233C62231903 @default.
• W4287149233 hasConceptScore W4287149233C62478195 @default.
• W4287149233 hasConceptScore W4287149233C86554907 @default.
• W4287149233 hasConceptScore W4287149233C86803240 @default.
• W4287149233 hasConceptScore W4287149233C95444343 @default.
• W4287149233 hasConceptScore W4287149233C98490376 @default.
• W4287149233 hasIssue "15" @default.
• W4287149233 hasLocation W42871492331 @default.
• W4287149233 hasLocation W42871492332 @default.

• next